Observational studyBMC complementary medicine and therapies2025
Pharmacovigilance and herbal medicines safety: a cross-sectional study of healthcare professionals' knowledge, attitudes and practices in selected regions of Tanzania, 2021.
Observational study in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization recommends integrating the safety monitoring of herbal medicines into existing pharmacovigilance (PV) systems to avoid overburdening the healthcare systems and national PV centres. However, there are few reports (0.3%) of herbal medicine Adverse Drug Reactions (ADRs) in the global database originating from Africa. An efficient PV system requires the involvement and commitment of healthcare professionals since they are primary contacts in transferring safety information from patients and consumers to national regulatory authorities (NRAs).
objectivesThe aim of this study was to determine the healthcare professionals’ knowledge, attitudes and practices regarding PV and herbal medicine safety in Tanzania.
methodsAn observational, cross-sectional, multicentre study was conducted in five regions of Tanzania, involving healthcare professionals working in pharmacies, hospitals, health centres, dispensaries and accredited drug dispensing outlets. Researcher-administered questionnaires were used.
resultsA total of 380 healthcare professionals participated in the study. The findings showed the majority of the healthcare professionals (65.8%) scored low on knowledge of PV and herbal medicines ADRs (62.9%). Although most respondents (86.8%) expressed favourable attitudes towards ADR reporting, this did not translate into practice, as only a small proportion (22.9%) actively reported ADRs to the NRA, with only 18.4% of the submitted case reports composed of herbal medicines. Most healthcare professionals (70.8%) perceived herbal medicines to be safer than conventional medicines. ADR reports lacked important information for causality assessment and signal identification by the NRA. Reports included all herbal products regardless of their source or origin. Professional background was a significant predictor of knowledge of PV (p < 0.001) and herbal medicines ADRs (p < 0.001). Pharmacovigilance training and the availability of ADR reporting forms were found to play a significant role in ADR reporting practices (p < 0.001).
conclusionsThe study revealed several gaps in the knowledge, attitudes and practices of healthcare professionals in PV and herbal medicines safety monitoring that require several interventions. Targeted efforts are required to promote knowledge and awareness of pharmacovigilance, herbal medicines and their safety to healthcare professionals at all healthcare system levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.